scholarly article | Q13442814 |
P356 | DOI | 10.1080/08916930500246339 |
P698 | PubMed publication ID | 16278146 |
P50 | author | Yehuda Shoenfeld | Q1515807 |
Miri Blank | Q73247232 | ||
P2093 | author name string | Levite M | |
Ganor Y | |||
Dobrynina LA | |||
Goldberg-Stern H | |||
Kalashnikova L | |||
P2860 | cites work | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 |
CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS | Q28201845 | ||
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy | Q28243859 | ||
Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 | ||
LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor | Q28360498 | ||
The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus | Q33333901 | ||
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
Unusual manifestations of the antiphospholipid syndrome | Q33348373 | ||
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model | Q33499900 | ||
Ketogenic diet, amino acid metabolism, and seizure control | Q34464773 | ||
Poststroke seizures | Q34530025 | ||
Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome | Q34735687 | ||
Central nervous system involvement in the antiphospholipid (Hughes) syndrome | Q35069507 | ||
CNS dysfunction in the antiphospholipid syndrome | Q35625224 | ||
Antiphospholipid syndrome infectious origin | Q35680777 | ||
Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy | Q36793709 | ||
Immunotherapy for epilepsy | Q37610210 | ||
Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site | Q41354036 | ||
Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis | Q43684869 | ||
GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. | Q43775117 | ||
Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures | Q44233555 | ||
Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera. | Q44260531 | ||
Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. | Q46501393 | ||
Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. | Q46566884 | ||
Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. | Q46615869 | ||
Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. | Q47801338 | ||
Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis? | Q48140719 | ||
Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. | Q48144813 | ||
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 | ||
Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis | Q48283010 | ||
Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. | Q54024916 | ||
P433 | issue | 6 | |
P921 | main subject | antiphospholipid syndrome | Q582207 |
P304 | page(s) | 417-424 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Autoimmunity | Q4826348 |
P1476 | title | Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome | |
P478 | volume | 38 |
Q79843433 | Autoantibodies: a novel etiology for refractory epilepsy? |
Q36473943 | Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). |
Q38235715 | Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep |
Q26738436 | Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. |
Search more.